FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

DVA

DaVitaNYSE · Health Care Services · Health Care
Previous close
187.50
Change
−5.81 / −3.01%
FinDog View
Bullish
52-Week Range ?
101.00 – 247.49
P/E (TTM) ?
13.5
Forward P/E ?
12.4
Based on consensus earnings for the next 12 months
Market Cap
$11.6B
1M
+7.19%
S&P 500 −0.91% over same period
Volume / Avg Volume
1.8M / 972K
1.81× average
Latest earnings analysisFY2026 Q2Reported 2026-08-04

DaVita Q2 FY2026: revenue up 5.2% to $3.55 billion, EPS $4.02

DaVita beat consensus earnings and grew revenue 5.2% to $3.55 billion, so our view is Bullish. The $4.02 per share came with a 16.3% operating margin and $490 million of operating cash flow, and full-year guidance implies a stronger second half. The caveats are a leveraged balance sheet and a book equity deficit, so the bullish case rests on cash generation rather than the balance sheet.

Read the full analysis →
Revenue$3.55BYoY +5.20%
EPS (non-GAAP)$4.02Beatest. $3.92
Next-day move−17.24%

Price History

Closing price · USD1M6M1Y5Y
100150200250EFY26 Q2 EarningsEFY26 Q1 EarningsEFY25 Q4 EarningsEFY25 Q3 Earnings2025-102026-012026-052026-082026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 15.61M6M1Y5Y
101520252023-112024-082025-052026-022026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2027-02-01
in 91 days · After hours
Consensus EPS
$4.49
Last quarter EPS $4.02
Avg. next-day move over the last 6 reports
±12.9%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 19 of its 5-year rangeCheap
5-year range 12.0 – 20.0 · Median 15.7
Last 4 quarters: $725M in buybacks + $0 in dividends, 6.26% of market cap combined
P/E (TTM)
13.5
P/B
94.5
P/S
0.8
PEG
0.38
Earnings Reaction
Over the last 6 reports, the stock moved ±12.9% on average on the first trading day after, rising 2 times
Most recent −17.24%
Volatility & Correlation
1-year beta -0.04 · Correlation with S&P 500 -0.01Low beta
Annualized volatility 47% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q33.58+4.6%—0.500.220.363.40
FY2026 Q23.55+5.2%—0.580.270.324.02
FY2026 Q13.42+6.0%—0.480.200.222.87
FY2025 Q43.62+9.9%—0.560.570.403.22
FY2025 Q33.42+4.8%—0.510.150.682.04
FY2025 Q23.38+6.1%—0.540.200.202.58
FY2025 Q13.22+5.0%—0.440.160.042.00
FY2024 Q43.29+4.7%—0.570.570.383.08
FY2024 Q33.26+4.6%—0.530.210.672.50
FY2024 Q23.19+6.2%—0.510.220.672.50
FY2024 Q13.07+6.9%—0.480.24-0.262.65
FY2023 Q43.15+7.8%—0.390.420.331.64

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView